EPISODE · Jul 9, 2026 · 1 MIN
Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction
from TheBrief.Health · host TheBrief.Health
Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.
What this episode covers
Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.
NOW PLAYING
Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m